A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples